South Korean company Seegene will supply ten million Covid-19 testing kits to Pan American Health Organization (PAHO) / World Health Organization (WHO) via Seegene do Brasil Diagnosticos, its Brazilian subsidiary. So far, the company has exported five million tests of Allplex 2019-nCOV assay to Brazil and the remaining five million will be supplied in the coming weeks. Seegene also plans to scale up its testing volume by up to 100%.
Gold Standard Diagnostics has announced the Emergency Use Authorization (EUA) submission of a Multiplex Real-Time, reverse-transcriptase polymerase chain reaction (RT-PCR) assay to detect the presence of Covid-19 causing SARS-CoV-2 virus. The assay is available in the US for purchase. The GSD NovaPrime SARS-CoV-2 (COVID-19) assay can simultaneously detect the two target sequences inside the N gene.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Kahala Biosciences and Rymedi have launched the ADIONA Covid-19 antibody testing platform. This platform is the first in the US that combines antibody testing with a blockchain-based smartphone software application, and claims to bring predictability and traceability to Covid-19 antibody testing. It combines a rapid point-of-care antibody (IgG/IgM) test carried out using a finger stick with an end-to-end blockchain solution.
South Korean coronavirus test kit maker 1-Drop has received EUA from US Food and Drug Administration (FDA) for its Covid-19 qPCR Multi Kit. With this approval, 1-Drop will be the sixth South Korean company to receive the EUA from the FDA. The company plans to boost the expansion to the North American market.
